TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of participants with fistula usable with intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of participants with fistula not usable
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: changes in forced expiratory volume in 1s (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: changes in breath way resistance (Rtot)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: urinary diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to short-term relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of readmission of patients
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Clinical Global Impression - Severity (CGI-S) Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of Breast Cancer Related Lymphedema (BCRL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Atrial and ventricular pacing thresholds in Volts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative peak airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative airway resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative plateau pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative lung compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 6 Month Progression-free Survival (6mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Radiographic Response Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants With Related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of the average score of Vaginal Health Index (VHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tiffeneau index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Level of agreement between TST and QTF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Serum 25-hydroxy Vitamin D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eckhard symptom scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: urine calcium concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Missing data
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Total grams of snack food consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enteral Intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Orthostatic Hypotension Associated Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in the tremor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood levels after a single dose of SB-649868
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Physician Global Assessment (PGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain stem auditory evoked response wave V latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Detection rate of VHL associated lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative Pulmonary Complication Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Zostavax immunizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haemagglutination inhibition (HAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of vaccine specific T-cell responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: area under the concentration-time curve from time 0 to infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from time 0 to time of the last measurable concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Activation Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Level Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functionality Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: arterial oxygen partial pressure (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Antibodies to infectious agents (IgG, IgM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Positive RT-PCR test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of phrenic nerve palsy
Endpoint domain: Adverse events/effects
Primary endpoint: Dynamic Lung Compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Concentration of antibiotics in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cardiac T2*
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Desire to Receive Advice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of FNA biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain on biting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stem and Cup Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of immune-related adverse events (irAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent Change From Baseline in EASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Bacteriological count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Iodine absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hyaluronan Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Modified Oswestry Disability Questionnaire (ODQ) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ratio of 6β-hydroxycortisol and 6β-hydroxycortisone to cortisol and cortisone in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pharmacokinetic parameters of immunosuppressive agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Days Homeless
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change From Baseline in Treatment Adherence Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Adherence Attitude Score (DAI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Restoration of menstruation cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Adolescent Body Mass Index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Proliferation as Measured by Ki-67
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Achieving Documented Change in Proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: major thrombotic events
Endpoint domain: Adverse events/effects
Primary endpoint: reoperation for any reason
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of P. aeruginosa resistance to imipenem (OprD mutation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent change of total atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relative lipid signal in the liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Modified MACTAR scale
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Medication adherence (caregiver perception)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dose of potassium chloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of NGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: immunotherapy response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease in Periodontal Pocket Depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Primary Composite Endpoint
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in average number of coughs per hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Worsening of force vital capacity (FVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Distribution Volume Ratio (DVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Secondary Graft Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Manic symptoms severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance use behavior scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of IUD Insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incremental area under the blood glucose curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 1st post-operative analgesic request
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Arthritis Impact Measurement Scale-2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Job Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: occupational situation of parents
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: number of participants reporting financial burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Spontaneous preterm labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Error rates
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in values registered in Magic Kegel App
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Blood Levels of Tumor Necrosis Factor Alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Blood Levels of Glutathione
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in Blood Levels of Interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Blood Levels of High Sensitivity C-Reactive Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ECG monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Subjects With Visibly Clean Lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With Change From Baseline in Contact Lens-Corrected Distance Visual Acuity (CLCDVA) by Line Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With an Excellent Ease of Intubation Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric pain Rating Scale (NPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with Adverse Events and Adverse Drug Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Elbow Extension Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of NAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of NAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height-for-age Z-score of index child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-height Z-score of index child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-age Z-score of index child
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy Rates Based on Pearl Index (PI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: trough concentration (C12hr) of nevirapine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Adverse events and device malfunctions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with Treatment-Emergent Adverse Events (TEAEs) by Severity in Part 1
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with Treatment-Emergent Adverse Events (TEAEs) by Severity in Part 2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Coughs Experienced by the Patient Within a 24-hour Period (24-hour cough count/hour) in Part 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Response Rates of PRNT80 Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean Skin Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of patients achieving treat to target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understanding of Immunosuppression Medication Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of Interventions to Support Medication Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of Barriers to Medication Adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of recurring BRCA1 and BRCA2 mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: proportion of patients who vomit within 15 minutes of administration of anti-emetic
Endpoint domain: Adverse events/effects
Primary endpoint: Nox2 presence in CNI nephrotoxic kidneys
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pre-operative Fasting Blood Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hospital Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Patients Who do Not Develop Hospital Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Epworth Sleepiness Scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Likert Score Rating Global Sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure frequency per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NRS worst pain intensity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence across the duration of the study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability and Acceptability of the intervention (qualitative interviews)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability and Acceptability of the intervention (System Usability Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability and Acceptability of the intervention (patterns of use data)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum diazepam levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longitudinal changes in prescriptions of 5-fluorouracil cream
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: systemic cytomegalovirus (CMV) infection detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in subjective symptoms of well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decrease in high sensitivity C-reactive protein (hsCRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Ventilator-associated Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: disc height retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lordosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ratings of acceptability intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ratings of liking intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of change of BCLC stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of Subjects With Hypercalcemia
Endpoint domain: Adverse events/effects
Primary endpoint: Sexual desires
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum plasma concentration (Cmax) of ACT-541468
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve [AUC(0-24)] of ACT-541468
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal half-life (t1/2) of ACT-541468
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in appetite, desire to eat, pleasure in eating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative complications of pain
Endpoint domain: Adverse events/effects
Primary endpoint: Vocal fold angle at anterior commissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urinalysis Benzoylecgonine (Cocaine Metabolite)(ng/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication Side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Compartment pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival rate of Lactobacillus salivarius
Endpoint domain: Mortality/survival
Primary endpoint: Change of analgesia duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Subjects Experiencing Treatment Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Treatment Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Subjects Experiencing Dose-Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Virologic Suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PANNAS questionnaire modified for attention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tmax of morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Other pharmacokinetic parameters of morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in height-for-age z-scores (HAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness of participants to be randomised
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of adverse psychiatric events
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic Accuracy of vHVPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaire to score asthma and common cold complaints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathological tumour response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Acute Otitis Media Symptom Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psoriatic infiltrate thickness (PIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Achieve an Adequate Epidural Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in fMRI activation of food motivation brain regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Objective Neuromuscular Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes